Accessibility Menu
 
Entia Biosciences logo

Entia Biosciences

(OTC) ERGO

Current Price$0.00
Market Cap$3,400
Since IPO (2008)-100%
5 Year-99%
1 Year+0%
1 Month-67%

Entia Biosciences Financials at a Glance

Market Cap

$3,400

Revenue (TTM)

$265.47K

Net Income (TTM)

$1.47M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-6.46 (Low)

Price

$0.00

Volume

100

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.04

ERGO News

No articles available.

ERGO: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Entia Biosciences

Industry

Personal Products

Headquarters

Sherwood, OR 97140, US

ERGO Financials

Key Financial Metrics (TTM)

Gross Margin

66%

Operating Margin

-4%

Net Income Margin

-6%

Return on Equity

0%

Return on Capital

70%

Return on Assets

-3%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.40K

Shares Outstanding

33.66M

Volume

100

Short Interest

0.00%

Avg. Volume

234

Financials (TTM)

Gross Profit

$173.97K

Operating Income

$1.17M

EBITDA

$1.29M

Operating Cash Flow

$715.10K

Capital Expenditure

$7.12K

Free Cash Flow

$722.22K

Cash & ST Invst.

$76.05K

Total Debt

$1.05M

Entia Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q4 2016YOY CHG

Revenue

$45.99K

-32.8%

Gross Profit

$35.87K

-3.9%

Gross Margin

77.99%

N/A

Market Cap

$3.40K

N/A

Market Cap/Employee

$566.67

N/A

Employees

6

N/A

Net Income

$469.74K

-51.5%

EBITDA

$385.69K

-135.2%

Quarterly Fundamentals

Name
Q4 2016YOY CHG

Net Cash

$969.95K

-280.2%

Accounts Receivable

$7.97K

+12.3%

Inventory

$69.76K

+73.0%

Long Term Debt

$300.08K

N/A

Short Term Debt

$745.92K

+167.1%

Return on Assets

-3.35%

N/A

Return on Invested Capital

70.05%

N/A

Free Cash Flow

$439.96K

-633.9%

Operating Cash Flow

$439.96K

-640.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BNGIBangi Inc.
$0.00+0.00%
PANCPanacos Pharmaceuticals, Inc.
$0.00+0.00%
BTTXBetter Therapeutics, Inc.
$0.00-50.00%
DNAGDNAPrint Genomics, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.52+0.03%
TQQQProShares Trust - ProShares UltraPro Qqq
$37.89-0.02%
ONDSOndas
$8.15-0.07%
QQQInvesco QQQ Trust
$558.28-0.01%

Questions About ERGO

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.